-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Predictive Oncology Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2011 to 2023.
- Predictive Oncology Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 6.4M shares, a 58.7% increase year-over-year.
- Predictive Oncology Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 4.01M shares, a 8.92% increase from 2022.
- Predictive Oncology Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 3.69M shares, a 93.3% decline from 2021.
- Predictive Oncology Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 54.9M shares, a 359% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)